Stay updated with breaking news from Agrx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com started coverage on shares of Agile Therapeutics (NASDAQ:AGRX – Free Report) in a research report report published on Sunday. The firm issued a hold rating on the specialty pharmaceutical company’s stock. Separately, Maxim Group raised shares of Agile Therapeutics from a hold rating to a buy rating and set a $5.00 target price on […]
StockNews.com assumed coverage on shares of Agile Therapeutics (NASDAQ:AGRX – Free Report) in a report released on Friday morning. The firm issued a hold rating on the specialty pharmaceutical company’s stock. Separately, Maxim Group raised shares of Agile Therapeutics from a hold rating to a buy rating and set a $5.00 price target on the […]
Agile Therapeutics, Inc. (NASDAQ:AGRX – Get Free Report) was the target of a large decrease in short interest in October. As of October 15th, there was short interest totalling 4,400 shares, a decrease of 76.5% from the September 30th total of 18,700 shares. Currently, 0.2% of the company’s shares are sold short. Based on an […]
Maxim Group upgraded shares of Agile Therapeutics (NASDAQ:AGRX – Free Report) from a hold rating to a buy rating in a research report sent to investors on Friday, Marketbeat.com reports. They currently have $5.00 price target on the specialty pharmaceutical company’s stock. Several other research analysts have also commented on the company. HC Wainwright reiterated […]
AGRX | Complete Agile Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.